Matches in Wikidata for { <http://www.wikidata.org/entity/Q64088931> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q64088931 description "article scientifique publié en 2019" @default.
- Q64088931 description "im März 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q64088931 description "wetenschappelijk artikel" @default.
- Q64088931 description "наукова стаття, опублікована в березні 2019" @default.
- Q64088931 name "Safety and Efficacy of Rivaroxaban When Added to Aspirin Monotherapy Among Stabilized Post‐Acute Coronary Syndrome Patients: A Pooled Analysis Study of ATLAS ACS‐TIMI 46 and ATLAS ACS 2‐TIMI 51" @default.
- Q64088931 name "Safety and Efficacy of Rivaroxaban When Added to Aspirin Monotherapy Among Stabilized Post‐Acute Coronary Syndrome Patients: A Pooled Analysis Study of ATLAS ACS‐TIMI 46 and ATLAS ACS 2‐TIMI 51" @default.
- Q64088931 type Item @default.
- Q64088931 label "Safety and Efficacy of Rivaroxaban When Added to Aspirin Monotherapy Among Stabilized Post‐Acute Coronary Syndrome Patients: A Pooled Analysis Study of ATLAS ACS‐TIMI 46 and ATLAS ACS 2‐TIMI 51" @default.
- Q64088931 label "Safety and Efficacy of Rivaroxaban When Added to Aspirin Monotherapy Among Stabilized Post‐Acute Coronary Syndrome Patients: A Pooled Analysis Study of ATLAS ACS‐TIMI 46 and ATLAS ACS 2‐TIMI 51" @default.
- Q64088931 prefLabel "Safety and Efficacy of Rivaroxaban When Added to Aspirin Monotherapy Among Stabilized Post‐Acute Coronary Syndrome Patients: A Pooled Analysis Study of ATLAS ACS‐TIMI 46 and ATLAS ACS 2‐TIMI 51" @default.
- Q64088931 prefLabel "Safety and Efficacy of Rivaroxaban When Added to Aspirin Monotherapy Among Stabilized Post‐Acute Coronary Syndrome Patients: A Pooled Analysis Study of ATLAS ACS‐TIMI 46 and ATLAS ACS 2‐TIMI 51" @default.
- Q64088931 P1433 Q64088931-2B724FA1-4DB0-4853-9E08-33EAD7D44FC3 @default.
- Q64088931 P1476 Q64088931-099197E1-4E4D-4D12-A9E9-0502C4949F87 @default.
- Q64088931 P2093 Q64088931-5556FC17-896F-4594-B6E1-D60A6B8013F5 @default.
- Q64088931 P2093 Q64088931-62F0DF35-AB37-4112-98B0-38F9A74E716D @default.
- Q64088931 P2093 Q64088931-9647D2A6-6D79-4F06-B959-8760E7221085 @default.
- Q64088931 P2093 Q64088931-B178847D-93D2-4D78-8ABF-AF5ECAE8D0B0 @default.
- Q64088931 P2093 Q64088931-D834D8B1-24E9-4870-9E87-0FB20A6D0D63 @default.
- Q64088931 P2093 Q64088931-DA6E76DF-8D67-4D28-AF56-65CCA02B1702 @default.
- Q64088931 P2093 Q64088931-FAFDBA60-057B-4465-A4E0-DEE8529734B3 @default.
- Q64088931 P31 Q64088931-5B78DE23-149F-47F5-B446-845FD0F7FBE4 @default.
- Q64088931 P356 Q64088931-E2583B53-9E75-47A6-996C-9D3AC8BEAC0D @default.
- Q64088931 P433 Q64088931-64B80D3C-9DD6-4EF8-901C-9BCE2748A574 @default.
- Q64088931 P478 Q64088931-0C082169-CCCD-4639-973B-7EE924282299 @default.
- Q64088931 P50 Q64088931-91988BE4-6834-47CD-88A0-08EE0245A9DC @default.
- Q64088931 P577 Q64088931-5434061E-5995-4152-9D7D-FC57A1CFCB11 @default.
- Q64088931 P921 Q64088931-121D7982-BBC9-4EFF-BC4E-147BA6969640 @default.
- Q64088931 P932 Q64088931-71A599CA-2D0C-408B-A095-B48D07168C88 @default.
- Q64088931 P356 JAHA.118.009451 @default.
- Q64088931 P1433 Q19880670 @default.
- Q64088931 P1476 "Safety and Efficacy of Rivaroxaban When Added to Aspirin Monotherapy Among Stabilized Post‐Acute Coronary Syndrome Patients: A Pooled Analysis Study of ATLAS ACS‐TIMI 46 and ATLAS ACS 2‐TIMI 51" @default.
- Q64088931 P2093 "Alexei N. Plotnikov" @default.
- Q64088931 P2093 "C. Michael Gibson" @default.
- Q64088931 P2093 "Megan K. Yee" @default.
- Q64088931 P2093 "Paul Burton" @default.
- Q64088931 P2093 "Serge Korjian" @default.
- Q64088931 P2093 "William J. Gibson" @default.
- Q64088931 P2093 "Yazan Daaboul" @default.
- Q64088931 P31 Q13442814 @default.
- Q64088931 P356 "10.1161/JAHA.118.009451" @default.
- Q64088931 P433 "5" @default.
- Q64088931 P478 "8" @default.
- Q64088931 P50 Q322114 @default.
- Q64088931 P577 "2019-03-05T00:00:00Z" @default.
- Q64088931 P921 Q18216 @default.
- Q64088931 P932 "6474929" @default.